Skip to main content

Advertisement

Log in

Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study

  • Research
  • Published:
Pathology & Oncology Research

Abstract

In this paper we report a molecular study of a case of Primary Endometrial Squamous Carcinoma (PESC), in which a Human Papilloma Virus (HPV) infection had been previously excluded by Polymerase Chain Reaction (PCR). The studies performed in an effort to explain the carcinogenesis included immunohistochemical over-expression of p53 and p16 proteins as previously observed in our own papers, plus microsatellite analysis of D10S1765 at 10q23.3 (PTEN) and TP53 at 17p13.1 (P53) as well as the methylation status of the of BRCA1 and p16 promoters using specific PCRs. In this rare malignancy, we found allelic imbalance (AI) at 17p13.1 (P53). Instead, AI at D10S1765 (PTEN) gene was absent. The genetic alteration of p53, with hyper-expression of p53 protein and an absence of abnormalities in the PTEN gene are consistent with the similarities between Uterine Serous Carcinoma (USC) and our case of PESC. The aberrant methylation of both p16 and BCAR1 promoters was not detected in our case. This finding too could imply that ESC is more similar to Uterine Serous Carcinoma than Uterine Endometrioid Carcinoma (UEC). Moreover, the lack of aberrant methylation of p16, which is in accordance with over-expression of p16 immunoreactivity, in the absence of HPV infection may be related to other unknown genetic alterations. In our opinion, it is hard to reach any definite conclusion concerning the carcinogenesis of PESC, because of its rarity and the very few molecular studies reported in the literature. Further studies with more numerous cases and larger molecular analyses are mandatory for this malignancy, to confirm whether it is more closely related to papillary endometrial cancer than to endometrioid carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig 2

Similar content being viewed by others

References

  1. Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276–284

    Article  PubMed  CAS  Google Scholar 

  2. Kataoka A, Nishida T, Sugiyama T, Hori K, Honda S, Yakushiji M (1997) Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol 65:180–184

    Article  PubMed  CAS  Google Scholar 

  3. Pins MR, Young RH, Crum CP, Leach IH, Scully RE (1997) Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis. Int J Gynecol Pathol 16:272–278

    Article  PubMed  CAS  Google Scholar 

  4. Wang Z, Dong J, Eyzaguirre EJ, Tang WW, Eltorky MA, Qiu S (2009) Detection of human papilloma virus subtypes 16 and P16(ink4a) in invasive squamous cell carcinoma of the fallopian tube and concomitant squamous cell carcinoma in situ of the cervix. J Obstet Gynaecol Res 35:385–389

    Article  PubMed  CAS  Google Scholar 

  5. Bifulco G, Giampaolino P, Mandato VD, Morra I, Nappi C, Insabato L (2011) Primary squamous cell carcinoma of the endometrium: a case report. Eur J Gynaecol Oncol 32:350–352

    PubMed  CAS  Google Scholar 

  6. Goodrich S, Kebria-Moslemi M, Broshears J, Sutton GP, Rose P. Primary squamous cell carcinoma of the endometrium: two cases and a review of the literature. Diagn Cytopathol. 2012 Jan 12. doi:10.1002/dc.22814. [Epub ahead of print]

  7. Giordano G, D’Adda T, Merisio C, Gnetti L (2005) Primary squamous carcinoma of the endometrium: a case report with immunohistochemical and molecular study. Gynecol Oncol 96:876–879

    Article  PubMed  Google Scholar 

  8. Giordano G, Azzoni C, D’Adda T, Merisio C (2007) P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas. Pathol Res Pract 7:533–538

    Article  Google Scholar 

  9. D’Adda T, Bottarelli L, Azzoni C et al (2005) Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors. Mod Pathol 18:795–805

    Article  PubMed  Google Scholar 

  10. Naidoo R, Chetty R (1998) The application of microsatellites in molecular pathology. Pathol Oncol Res 4:310–315

    Article  PubMed  CAS  Google Scholar 

  11. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826

    Article  PubMed  CAS  Google Scholar 

  12. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148–1159

    Article  PubMed  CAS  Google Scholar 

  13. Weissenbach J, Gyapay G, Dib C et al (1992) A second-generation linkage map of the human genome. Nature 359:794–801

    Article  PubMed  CAS  Google Scholar 

  14. Peltomaki P, Lothe RA, Aaltonen LA et al (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53:5853–5855

    PubMed  CAS  Google Scholar 

  15. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561

    Article  PubMed  CAS  Google Scholar 

  16. Wirtz HC, Muller W, Noguchi T et al (1998) Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res 4:1749–1754

    PubMed  CAS  Google Scholar 

  17. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D (1994) Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 86:1216–1221

    Article  PubMed  CAS  Google Scholar 

  18. Steele RJC, Thompson AM, Hall PA, Lane DP (1998) The p53 tumour suppressor gene. Br J Surg 85:1460–1467

    Article  PubMed  CAS  Google Scholar 

  19. Ziyaie D, Hupp TR, Thompson AM (2000) p53 and breast cancer. Breast 9:239–246

    Article  PubMed  CAS  Google Scholar 

  20. Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5:2851–2855

    PubMed  CAS  Google Scholar 

  21. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539

    PubMed  CAS  Google Scholar 

  22. Lakshmi S, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR (1997) p53 protein and tumorigenesis in the uterine cervix. Gen Diagn Pathol 142:281–287

    PubMed  CAS  Google Scholar 

  23. Reihsaus E, Kohler M, Kraiss S et al (1990) Regulation of the level of the oncoprotein p53 in non transformed and transformed cells. Oncogene 5:137–145

    PubMed  CAS  Google Scholar 

  24. Munn KE, Walker RA, Menasce L, Varley JM (1996) Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ. Br J Cancer 74:1578–1585

    Article  PubMed  CAS  Google Scholar 

  25. Steck PA, Perhouse MA, Jasser SA et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362

    Article  PubMed  CAS  Google Scholar 

  26. Li J, Yen C, Liaw D et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1946

    Article  PubMed  CAS  Google Scholar 

  27. Bussaglia E, del Rio E, Matias-Guiu X, Prat J (2000) PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 31:312–317

    Article  PubMed  CAS  Google Scholar 

  28. Levine RL, Cargile CB, Blazes MS, van Rees B, Kurman RJ, Ellenson LH (1998) PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3254–3258

    PubMed  CAS  Google Scholar 

  29. Maxwell GL, Risinger JI, Gumbs C et al (1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58:2500–2503

    PubMed  CAS  Google Scholar 

  30. Mutter GL (2001) PTEN, a protean tumor suppressor. Am J Pathol 158:1895–1898

    Article  PubMed  CAS  Google Scholar 

  31. Omura-Minamisawa M, Diccianni MB, Chang RC et al (2001) p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Clin Cancer Res 7:3481–3490

    PubMed  CAS  Google Scholar 

  32. Esteller M, Silva JM, Dominguez G et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564–569

    Article  PubMed  CAS  Google Scholar 

  33. Wong YF, Chung TK, Cheung TH et al (1999) Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 136:231–235

    Article  PubMed  CAS  Google Scholar 

  34. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

    Article  PubMed  CAS  Google Scholar 

  35. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182

    Article  PubMed  CAS  Google Scholar 

  36. Kerr P, Ashworth A (2001) New complexities for BRCA1 and BRCA2. Curr Biol 11:R668–R676

    Article  PubMed  CAS  Google Scholar 

  37. Shen S-X, Weaver Z, Xu X et al (1998) A targeted disruption of the murine BRCA1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17:3115–3124

    Article  PubMed  CAS  Google Scholar 

  38. Foray N, Randrianarison V, Mrot D, Perricaudet M, Lenoir G, Feunteun J (1999) Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18:7334–7342

    Article  PubMed  CAS  Google Scholar 

  39. Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37–43

    Article  PubMed  CAS  Google Scholar 

  40. Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A (2000) Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21:147–151

    Article  PubMed  CAS  Google Scholar 

  41. Baldwin RL, Nemeth E, Tran H et al (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60:5329–5333

    PubMed  CAS  Google Scholar 

  42. Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738

    PubMed  CAS  Google Scholar 

  43. Seeber LM, Zweemer RP, Marchionni L et al (2010) Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 17:663–673

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The Authors wish to thank Professor Alex Gillan for his help with the English translation and Mrs Emilia Corradini for technical assistence.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanna Giordano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giordano, G., Pizzi, S., Azzoni, C. et al. Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study. Pathol. Oncol. Res. 19, 495–499 (2013). https://doi.org/10.1007/s12253-013-9607-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9607-3

Keywords

Navigation